Colfax

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Colfax (CFX) reported earnings 30 days ago. What's next for the stock?

Why Is Colfax (CFX) Up 22.4% Since Last Earnings Report?

Colfax (CFX), with a 23% decline in shares so far in 2020, faces the adverse impacts of the pandemic. High debts and forex woes are other concerns.

Colfax (CFX) Declines 23% YTD: What's Hurting the Stock?

Colfax Corporation (CFX) CEO Matthew Trerotola on Q1 2020 Results - Earnings Call Transcript

Colfax's (CFX) Q1 results reflect the adverse impacts of the pandemic and contributions from the DJO Global buyout. It withdraws projections for 2020, while expects demand to be the lowest in the second quarter.

Colfax (CFX) Beats Q1 Earnings Estimates, Withdraws View

Colfax (CFX) delivered earnings and revenue surprises of 2.70% and 3.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Colfax (CFX) Beats Q1 Earnings and Revenue Estimates

Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Colfax (CFX) Q1 Earnings Expected to Decline

Colfax (CFX) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Colfax (CFX) Surges: Stock Moves 6.1% Higher

ANNAPOLIS JUNCTION, MD , April  27, 2020  (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that due to public health considerations arising from the coronavirus outbreak (COVID-19) and to support the health and well-being of its stockholders and employees, the format of the Annual Meeting has been changed and now will be held solely by means of remote communication, in a virtual format. As previously announced, the Annual Meeting will be held on Thursday, May 21, 2020 at 3:00 p.m. EDT. The items of business are the same as previously announced. Stockholders will not be able to attend the Annual Meeting in person.

Colfax Corporation to Hold 2020 Annual Meeting of Stockholders  in Virtual Format Due to COVID-19 Precautions

Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses, productivity actions and acquisitions. However, rising cost of sales and high debt remain concerns.

Colfax (CFX) Displays Bright Prospects, Headwinds Remain

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Colfax (CFX) a Great Value Stock Right Now?

Colfax (CFX) Down 55.3% Since Last Earnings Report: Can It Rebound?

Is Colfax (CFX) a great pick from the value investor's perspective right now? Read on to know more.

Should Value Investors Pick Colfax (CFX) Stock Right Now?

Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses and productivity actions, and gains from acquired assets. Cost of sales witnesses a rise.

Colfax to Gain From Solid Product Lines & Buyouts Amid Risks

Colfax Corporation (CFX) CEO Matt Trerotola on Q4 2019 Results - Earnings Call Transcript

Colfax's (CFX) fourth-quarter 2019 results benefit from growth in existing businesses and acquired assets despite forex woes.

Colfax (CFX) Q4 Earnings & Revenues Beat Estimates, Up Y/Y

Colfax (CFX) delivered earnings and revenue surprises of 8.93% and 0.70%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Colfax (CFX) Surpasses Q4 Earnings and Revenue Estimates

Earnings Preview: Colfax (CFX) Q4 Earnings Expected to Decline

Colfax (CFX) is likely to gain from acquired assets, healthy medical technology business and emerging market exposure. High costs, forex woes and huge debts are concerns.

Colfax (CFX) Benefits From Acquired Assets Despite Costs Woes

Colfax (CFX) benefits from acquisitions, productivity actions and product developments. However, escalating costs and a highly leveraged balance sheet are headwinds.

Colfax's (CFX) Shares Rally 33.4% in 6 Months: Here's Why

Annapolis Junction, MD, Dec.  11, 2019  (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading global manufacturer of medical technology and fabrication technology products and services, today announced that it has appointed Liam Kelly, President and CEO of Teleflex Incorporated, to its Board of Directors effective January 1, 2020.  This appointment increases the size of Colfax's Board of Directors to ten members.  

Liam Kelly Appointed to Colfax Board of Directors

Colfax (CFX) is likely to continue benefiting from acquisitions, productivity actions and product developments. However, a highly leveraged balance sheet remains a concern.

Colfax (CFX) Shares Up 57.7% YTD: What's Driving the Rally?

Colfax's (CFX) third-quarter 2019 results benefit from improved sales performance, with buyouts playing a significant role.

Colfax (CFX) Q3 Earnings Beat Estimates, Up Y/Y on Buyouts

Colfax Corporation (CFX) CEO Matt Trerotola on Q3 2019 Results - Earnings Call Transcript

Colfax (CFX) delivered earnings and revenue surprises of 8.70% and -0.10%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Colfax (CFX) Surpasses Q3 Earnings Estimates

Annapolis Junction, MD, Oct.  23, 2019  (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax”) (NYSE: CFX), today announced that it will be presenting at Baird’s 2019 Global Industrial Conference in Chicago, Illinois, on November 5, 2019 at 2:30 pm CST (3:30 pm EST).  A live presentation of this event will be available via Colfax’s website at www.colfaxcorp.com under the “Investors” section.  Replays will also be available on the Company’s website following the event.

News for Colfax Stock (CFX)